Acquired perforating dermatosis. Case report of two patients with diabetes mellitus and chronic renal disease undergoing hemodialysis
Abstract
Perforating dermatoses (PD) represent a heterogeneous group of inherited or acquired diseases characterized by transepidermal migration of dermis extracellular matrix components (collagen, elastic tissue or necrotic connective tissue) following an inflammatory and/or degenerative process.
The etiopathogenesis of acquired perforating dermatosis (APD) is unknown. However, it is strongly associated with minor trauma, chronic renal failure and diabetes mellitus and, less frequently, with endocrinological diseases, infectious diseases, neoplastic growth, among others.
Acquired perforating dermatoses are diagnosed in 10-12 % of patients undergoing hemodialysis. Itching constitutes the main symptom of this disorder. In some cases, it may be incapacitating and secondary excoriation due to scratching may cause extensive lesions altering the skin barrier function.
We report the cases of two patients undergoing hemodialysis three times a week, both with a history of diabetes mellitus and end-stage chronic renal failure requiring renal replacement therapy (RRT). These patients presented with generalized itching dermatosis which had been going on for months. Upon physical examination, raised, hyperpigmented lesions with an umbilicated center and surrounded by an erythematous halo were observed on the face, trunk and limbs. Histopathological examination revealed APD.
References
Herrera Ceballos E, Moreno Carazo A, Requena Caballero L, Rodríguez Peralto J. Dermatología. Correlación clínico patológica. Buenos Aires: Grupo Menarini, 2007. 641 p.
Rapini RP. Perforating Diseases. En: Dermatology. Edited by JL Bolognia, JL Jorizzo, RP Rapini, et al. 2nd ed. [St. Louis, Mo.]: Mosby, Elsevier, 2008, p. 1461-7.
Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis. Report of six cases and review of the literature. J Am Acad Dermatol. 1994;30(4):575-80.
Karpouzis A, Giatromanolaki A, Sivridis E, Kouskoukis C. Acquired reactive perforating collagenosis: current status. J Dermatol. 2010;37(7):585-92.
Gómez ML, Busso SP, Santoro G, Cabrera HN. Manifestaciones cutáneas en pacientes hemodializados: a propósito de 150 casos, análisis casuístico. Arch Argent Dermatol. 1995;45(1):3-10.
Rapini RP, Herbert AA, Drucker CR. Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers. Arch Dermatol. 1989;125(8):1074-8.
Castellanos Possee ML, Nocito MJ, Marchesi C, Garuti RA, Carmona Cuello LE, Capelli L, et al. Dermatosis perforantes, presentación de 8 casos. Med Cutan Ibero Lat Am. 2012;40(5-6):147-53.
García-Salcesa I, Grasaa MP, Carapetoa FJ. Dermatosis perforante adquirida por un paciente diabético. Piel. 2008;23(7):341-3.
Mehregan AH, Schwartz OD, Livingood CS. Reactive perforating collagenosis. Arch Dermatol. 1967;96(3):277-82.
Minocha J, Schlosser B. Trastornos perforantes adquiridos. En: Fitzpatrick. Dermatología en Medicina General. Buenos Aires: Panamericana, 2012. p. 727-31.
Mehregan AH, Coskey RJ. Perforating folliculitis. Arch Dermatol. 1968;97(4):394-9.
Ortiz AM, Navarrete FG. Dermatosis perforantes reactivas en el Centro Dermatológico Dr. Ladislao de la Pascua en 55 años. Dermatol Rev Mex. 2013;57(2):111-7.
Arias M, La Forgia M, Buonsante ME, Portaluppi M, Kien MC, Pellerano G. Dermatosis perforante adquirida en pacientes con insuficiencia renal crónica. Comunicación de tres casos y revisión de la literatura. Dermatol Argent. 2007;13(3):184-9.
Rodríguez-Patiño G, Mercadillo-Pérez P. Dermatosis perforantes. Características clinicopatológicas en México. Rev Med Hosp Gen Mex. 2009;72(1):20-5.
Fujimoto E, Kobayashi T, Fujimoto N, Akiyama M, Tajima S, Nagai R. AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: epidermal-dermal interaction in acquired perforating dermatosis. J Invest Dermatol. 2010;130(2):405-14.
Gambichler T, Birkner L, Stücker M, Othlinghaus N, Altmeyer P, Kreuter A. Up-regulation of transforming growth factor-beta3 and extracellular matrix proteins in acquired reactive perforating collagenosis. J Am Acad Dermatol. 2009;60(3):463-9.
Saray Y, Seçkin D, Bilezikçi B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol. 2006;20(6):679-88.
Luna P, Nocito M, Etcheverry M, Cañadas N, Lustia M, Mazzini MA, et al. Dermatosis perforante adquirida en un paciente sin insuficiencia renal crónica ni diabetes. Dermatol Argent. 2006;12(5):326-7.
Ghosh SK, Bandyopadhyay D, Chatterjee G. Acquired reactive perforating collagenosis following insect bite. Indian J Dermatol Venereol Leprol. 2009;75(3):306-7.
Arredondo MI, Londoño A, Restrepo R. Enfermedades con eliminación transepidérmica. Rev Asoc Col Dermatol. 2008;16(3):185-95.
Kasiakou SK, Peppas G, Kapaskelis AM, Falagas ME. Regression of skin lesions of Kyrle’s disease with clindamycin: implications for an infectious component in the etiology of the disease. J Infect. 2005;50(5):412-6.
Calb IL, Spillman DH. Colagenosis perforantes reactivas. En: Torres Lozada V. Dermatología práctica ibero-latinoamericana: atlas, enfermedades sistémicasasociadas y terapéutica. México, D.F.: Nieto Editores, 2005. p. 1096-8.
Munch M, Balslev E, Jemec GB. Treatment of perforating collagenosis of diabetes and renal failure with allopurinol. Clin Exp Dermatol. 2000;25(8):615-6.
Desco MC, Asensi M, Márquez R, Martínez-Valls J, Vento M, Pallardó FV, et al. Xanthine oxidase is involved in free radical production in type1 diabetes: protection by allopurinol. Diabetes. 2002;51(4):1118-24.
Iyoda M, Hayashi F, Kuroki A, Shibata T, Kitazawa K, Sugisaki T, et al. Acquired reactive perforating collagenosis in a nondiabetic hemodialysis patient: successful treatment with allopurinol. Am J Kidney Dis. 2003;42(3):E11-3.
